New Perspectives of Dyrk1A Role in Neurogenesis and Neuropathologic Features of Down Syndrome-Reference-Cited by-同舟云学术

New Perspectives of Dyrk1A Role in Neurogenesis and Neuropathologic Features of Down Syndrome

Published:2013-12-30 Issue:4 Volume:22 Page:244-248
ISSN:1226-2560
Container-title:Experimental Neurobiology
language:en
Short-container-title:Exp Neurobiol

Author:

Park Joongkyu¹²,Chung Kwang Chul¹

Affiliation:

1. Department of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, Korea

2. Program in Cellular Neuroscience, Neurodegeneration and Repair (CNNR), Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT 06510, USA

Funder

Ministry for Health and Welfare

National Research Foundation

Publisher

The Korean Society for Brain and Neural Science

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Link

https://synapse.koreamed.org/pdf/10.5607/en.2013.22.4.244

Reference40 articles.

1. Chromosome 21 and Down syndrome: from genomics to pathophysiology

2. Down's syndrome

3. Risks of leukaemia and solid tumours in individuals with Down's syndrome

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Skeletal health in DYRK1A syndrome;Frontiers in Neuroscience;2024-09-06

2. DYRK1A Interacts with the Tuberous Sclerosis Complex and Promotes mTORC1 Activity;2024-08-20

3. Discovery of a novel chemotype as DYRK1A inhibitors against Alzheimer's disease: Computational modeling and biological evaluation;International Journal of Biological Macromolecules;2024-06

4. Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy;European Journal of Medicinal Chemistry;2024-05

5. Dual-specificity kinase DYRK3 phosphorylates p62 at the Thr-269 residue and promotes melanoma progression;Journal of Biological Chemistry;2024-04